Alemtuzumab as part of conditioning therapy for Graft-Vs-Host Disease in children and young adults 05/05/2021 Research min. read Copied to clipboard Topics cancer Acute Lymphoblastic Leukemia (ALL) acute myeloid leukemia lymphoma Read Full media story at www.hematologyadvisor.com Related Stories Research Jul 23, 2026 Comprehensive Brain Atlas Uncovers Unique Neurons Behind Complex Information Processing Research Jul 17, 2026 Texas Children’s Cancer & Hematology Center Faculty Earn Approximately $2 Million in New Resear... Awards Jul 17, 2026 CNRC Investigator Douglas Burrin Awarded NIDDKD Award Research Jul 16, 2026 Bellen Lab researchers uncover a novel epilepsy pathway Research Jul 13, 2026 22nd Annual Research Symposium Highlights Advances in Pediatric Cancer and Blood Disorders Research Jun 10, 2026 Understanding Rett syndrome before symptoms appear See more results 82841 Alemtuzumab as part of conditioning therapy for Graft-Vs-Host Disease in children and young adults Research Article